Johnson Controls Reports Strong Q3 Results; Raises FY26 Guidance
Q3 sales increased 9% and organic sales increased 10%* Q3 GAAP EPS of $1.23; Q3 Adjusted EPS* of $1.42 Q3 orders +27% organically year-over-year Backlog of $21.0... Read more.
EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease... Read more.
4Pines Fund Services Launches Next Generation of C2P, Introducing a Shared Operating Model for Fund Administration
New platform makes the entire fund administration process visible, auditable, and collaborative – for both sides of the relationship – in real time STAMFORD,... Read more.
Boston Scientific announces results for second quarter 2026
MARLBOROUGH, Mass., July 29, 2026 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.442 billion during the second quarter... Read more.
CGI reports third quarter Fiscal 2026 results
Stock Market SymbolsGIB.A (TSX)GIB (NYSE)cgi.com/newsroom Revenue up 2.5% and diluted EPS accretion of 22.5% Q3-F2026 performance highlights Revenue of $4.19 billion,... Read more.
ONEMAIN HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS
2Q 2026 Diluted EPS of $1.32 2Q 2026 C&I adjusted diluted EPS of $1.31 2Q 2026 Managed receivables of $26.9 billion Declared quarterly dividend of $1.05 per... Read more.
Aon Reports Second-Quarter 2026 Results
DUBLIN, July 29, 2026 /PRNewswire/ — Aon plc (NYSE: AON) today reported results for the three months ended June 30, 2026. Aon delivered another quarter of... Read more.
PROSPERITY BANCSHARES, INC.® REPORTS SECOND QUARTER 2026 EARNINGS
Completed the merger of Stellar Bancorp, Inc. into Prosperity Bancshares on July 1, 2026 Second quarter net interest margin increased 29 basis points to 3.47% compared... Read more.
Cognizant Reports Second Quarter 2026 Results
12% year-over-year revenue growth in Financial Services; $1.1 billion deployed on share repurchases Revenue of $5.5 billion increased 4.5% year-over-year or 4.1%... Read more.
Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026
STOCKHOLM, July 29, 2026 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today published the preliminary global revenue... Read more.